RESEARCH ARTICLE


https://doi.org/10.5005/jp-journals-10025-1188
International Journal of Keratoconus and Ectatic Corneal Diseases
Volume 9 | Issue 1 | Year 2020

Femtosecond Circular Keratotomy in Stage I and II Keratoconus

Jörg H Krumeich1, Nino Hirnschall2, Florian Laufer3

1,3Department of Ocular Surgery, Clinic Krumeich, Bochum, Germany

2Department of Ophthalmology and Optometry, Kepler University Clinic, Johannes Kepler University Linz, Linz, Austria

Corresponding Author: Jörg H Krumeich, Department of Ocular Surgery, Clinic Krumeich, Bochum, Germany, Phone: +49 2327 88008, e-mail: jk@krumeich.de

How to cite this article: Krumeich JH, Hirnschall N, Laufer F. Femtosecond Circular Keratotomy in Stage I and II Keratoconus. Int J Kerat Ect Cor Dis 2020;9(1):7–10.

Source of support: Nil

Conflict of interest: None

ABSTRACT

Aim and objective: Authors present clinical results of circular keratotomy (CTK) performed with a femtosecond laser. The 1–3 years results for two separate groups are the first results of a new surgical approach to stop progression of keratoconus.

Materials and methods: A circular intraparenchymal central 7-mm cut was made with a Ziemer Z6, Z8 femtosecond laser without affecting the epithelium, Bowman layer, Descemet layer and endothelium. Patients with stage I and II keratoconus according to the Krumeich classification were treated.

Results: In total 147 eyes were treated. Statistical evaluation showed stable radii in 87.8% (n = 48) of the eyes treated. Astigmatism was stable in 79.6% (n = 69). BCVA remained stable or improved in 75.9% (n = 29).

Conclusion: CKT is a procedure that reliably works in keratoconus stage I and II. Advantages are the ease of the performance using the femtosecond laser and the absence of any severe complication in the eyes treated. The eye remained closed with the consequence that no contact existed from the external world into the cornea.

Keywords: Circular corneal cut, Circular keratotomy, Keratoconus.

INTRODUCTION

Keratoconus is a congenital noninfectious progressive disease of the cornea. Eccentric tissue blebs and thinning out of parenchyma bilaterally show when presented. Classification according to the degree of steepening and irregularity is named in four stages. The diagnosis should be confirmed as early as possible. Still no conventional treatment stopping progression in stage I and II is found. Temporary use of contact lenses is the standard procedure to regain better vision but progression is not stopped. Only recently a 7-mm diameter incision circularly around the pupil, circular keratotomy (CKT), was published as an operation to stop progression in stages I and II.

Today various options to stop the progression of keratoconus in its early stages are available.

In 2000 Colin and Simonpoli-Velou introduced intrastromal ring segments, which were inserted into the cornea to improve corneal surface and vision.1

In 2003 corneal collagen cross-linking (CXL) was introduced by Wollensak et al.2 This procedure aims to strengthen the cornea by ultraviolet-A irradiation combined with Riboflavin. Different protocols are available with regard to radiation or amount of riboflavin to be used.2 Although the literature reports on a stable situation in eyes treated compared to control groups, the results failed to prove long-term corneal healing. Detrimental side effects such as the development of cancer around a deep lamellar transplant in a CXL-treated eye discourage the support of this procedure.3

CKT was introduced 2009 by Krumeich and Kezirian following the concept to create a scar to stabilize the diseased tissue in stage I and II.4 In 2016 A 5-years follow up of 51 eyes showed stable radii in 84.3%.5

In 2011 the implantation of complete rings (MyoRing, DIOPTEX GmbH, Linz, Austria) was introduced by Alio et al.6

In 2016 Krumeich et al. presented a modified CKT, in which the cut is performed with a femtosecond laser rather than a trephine.7 In continuation of the 1-year results in the above publication, now 3-year results are presented here.

NEW DIAGNOSTIC PROCEDURE

Keratoconus pathology was assumed to be present if there was visible evidence of double contours representing different refractive indices of front and back of the cornea. These double contours were present even at the very beginning of the disease.

We found that projection of a light circle onto a keratoconic cornea with an ophthalmometric apparatus always produced double images if keratoconic deformations were present. No double images were produced by scars in the cornea or if operations such as penetrating keratoplasty or deep anterior lamellar keratoplasty had been performed.

We used this technique to ensure that our findings and results truly arose from keratoconic origins. In particular, one can use this technique without a long learning curve. Apparently, the reflected image is the result of the different refractive indices of front and back of the conic cornea. This can also be seen at the early stage of the disease. A diagnosis based on double images requires an ophthalmometric device; however, such devices must not possess software that eliminates the weaker of the two images. The effect can be observed if one uses, f.i., the Bausch & Lomb, the Topcon OM4, the Zeiss Bomb or other devices using similar setups. To our knowledge, this is the first publication that uses front-to-back reflections of the measuring light circles thereby detecting keratoconic corneas if such double contours are present. The diagnosis and confirmation of keratoconus is certain also in the very beginning cases (Fig. 1).

Fig. 1: Keratometric picture identifying keratoconus

We preferred to use this diagnostic tool knowing that various other approaches are used to thoroughly define and analyze clinical signs and differential diagnosis. Such diagnostic approaches include corneal topography, Scheimpflug image assessment, wavefront analysis, corneal hysteresis and epithelial thickness profiles. Since the double contour technique was shown to be universally applicable and helps prevent surgeons from being seriously misled by misinterpretations, we used this technique for all cases reported in this paper.

Wound Healing

Since there is no known difference in corneal wound healing between healthy and keratoconic corneas, we assumed that the generation of an intraparenchymal cut within the conic cornea would create a stable scar. Examples of the stability of corneal parenchymal scars can be seen, for instance, in the stability of refraction of implanted rings in keratoconus eyes.

We decided to use a femtosecond laser cut beneath Bowman’s to exclude Bowman’s membrane from the healing process. The opening of the upper layers would expose the eye to the potentially unsterile outside world. Staying within the corneal parenchyma should therefore limit wound healing to the origin of the cut. Neither Bowman’s nor Descemet’s are touched.

MATERIALS AND METHODS

Out of the four available femtosecond lasers, three operate with high energy but with low repetition rates ranging from 40 to 160 kHz INTRALASE, Bausch & Lomb to 500 kHz VISUMAX, Zeiss. We chose the device with the lowest per-pulse energy. This device produced the highest repetition rate of 20.8 MHz, and its per-pulse energy was 10–20 nJ (Ziemer Z6, Z8, Table 1). The laser cuts the tissue from deep to shallow layers, and we found in the retrospective measurements of the first cases, as described in the previous paper that a cutting length of 375 µm from Descemet’s to Bowman’s membranes produced the expected effect. In particular, there was no vision-impairing or vision-reducing effect. All cuts were performed within the center of a 7-mm applanated area.

Table 1: Overview of femtosecond laser settings for different manufacturers
  Pulse repetition rate Laser pulse duration (fs) Wavelength (nm) Pulse energy (nJ) Spot size (µm)
AMO Intralase 150 kHz 600–800 1053 200–800 <1.8
ZEISS VisuMax 500 kHz 220–580 1043 100–260 N/A
B + L VICTUS 40, 80, 160 kHz 400–550 1028 n.a. n.a.
Ziemer LDV (or Z 2, 4, 6, 8) 20, 8 MHz 200–350 1045 10–20 1
Alcon WaveLight FS200 200 kHz 350 1030 2400 5

The angle of the cut within the applanated cornea was steeper than 45° to generate the same effect in all cases, avoiding only separating parallel layers.

There are no data on the traction forces that may be created by the cut. Healing of the tissue seemed to stabilize the surface with no influence on transparency either within the 7-mm zone or in the periphery of the cut.8 Early haze along the cut persisted several weeks but disappeared thereafter, which is different to the known haze that frequently appears after photorefractive keratoplasty.

The duration of the whole procedure was between 30 and 40 seconds.

The stability values of the K-readings were evaluated to determine if the progression of keratoconus had been halted. The 1-year postoperative keratometry values were used as a reference baseline to determine if the progression of keratoconus had been stopped 3-years after the operation. The statistical evaluation was begun within the 1-year postoperative period, as the results from this period were consistent among the patients. All refraction and radius data were measured with the same technique described above.

Preoperative best-corrected visual acuity (BCVA) values were used as a baseline to determine changes in visual acuity, which tend to show up frequently in the immediate postoperative period.

Progression of the cone was defined as follows:

Corneal optical coherence tomography was performed 1 day postoperatively and at every time point during the follow-up to evaluate possible cutting length modifications.

Statistical Analysis

For the statistical analyses, WinSTAT (V2012.1.0.96) for Microsoft Excel was used (Microsoft, Redmond, Washington, USA).

All data were evaluated according to their distributions as determined by the Kolmogorov–Smirnov test. As the data were not normally distributed, nonparametric testing was performed. Categorical data were tested using the Chi-square test, counted data were pairwise compared using the Wilcoxon signed-rank test, and correlation analysis was performed using Spearman’s rank-order correlation. A p <0.05 was considered significant.

Visual acuity data were converted from decimal to log MAR for the calculations.

Because not all eyes were available at every follow-up visit, two parallel evaluations were carried out. The first was for the consistent cohort, where only eyes with complete keratometry data at 1 and 3 years postoperatively were included. The second evaluation was carried out for all eyes with all data available from the follow-up.

RESULTS

Clinical Outcomes

In general all patients were satisfied with the operation technique with regard to duration and comfort of the operation.

On postoperative ocular coherence tomography, the cut demonstrated integration of the parallel organized tissue.

Wound healing did not generate opacifications within the 7-mm area (Fig. 2).

Fig. 2: Scar formation outside of the 7-mm central area. No change can be seen on the surface of parenchyma

Due to the separation of the tissue by the femtosecond laser blebs, opacifications were insofar different from those produced by a cut.

Statistical Outcomes

Consistent Cohort—Keratometry

The radii were stable within 1.0 D three years postoperatively for 41 eyes (83.67%, n = 49). Stable within 1.5 D were another 2 eyes (87.8%, n = 49). The mean K-readings at 1 year and 3 years postoperatively were 46.46 D (SD 2.02 D; median 46.05 D; range 42.38–51.50 D) and 46.87 D (SD 2.22 D; median 47.0 D; range 41.50–52.50 D), respectively. This difference was statistically significant (p = 0.002; n = 49). The K-readings of the consistent cohort are presented in Figure 3.

Fig. 3: K-readings values of consistent cohort

The change in K-readings 3 years postoperatively was 0.41 D (SD 1.4 D, range −5.95 to 4.35).

Consistent Cohort—Astigmatism

Astigmatism was stable for 39 eyes 1 year postoperatively (79.6%, n = 69).

The mean corneal astigmatism at 1 year and 3 years was 2.76 D (SD 1.82 D; median 2.80 D; range 0.10–8.70 D) and 3.54 D (SD 2.38 D; median 3.0 D; range 0.10–10.0 D), respectively. This difference was statistically significant (p = 0.025; n = 49). The astigmatism values of the consistent cohort are presented in Figure 4.

Fig. 4: Astigmatism values of consistent cohort

The change in mean astigmatism was 0.78 D (SD 1.98, range −2.5 to 6.5).

The changes in K-readings and astigmatism values are presented in Figure 5.

Fig. 5: Changes in K-readings and astigmatism

All Eyes—Keratometry

The radii were stable within 1.5 D 1 year postoperatively for 43 eyes (87.8%, n = 49).

The mean K-readings at 1 year (n = 86) and 3 years (n = 59) was 46.52 D (SD 2.14 D; median 46.22 D; range 42.0–53.0 D) and 46.89 D (SD 2.22 D; median 47.03 D; range 41.50–52.50 D), respectively. The mean K-readings of the consistent cohort are presented in Figure 6.

Fig. 6: K-readings values of all data

All Eyes—Astigmatism

Astigmatism was stable for 39 eyes 1 year postoperatively (79.6%, n = 69).

The mean corneal astigmatism at 1 year (n = 86) and 3 years (n = 59) was 2.90 D (SD 1.85 D; median 2.88 D; range 0.0–8.70 D) and 3.53 D (SD 2.41 D; median 3.0 D; range 0.10–10.0 D), respectively. The astigmatism values of the consistent cohort are presented in Figure 7.

Fig. 7: Astigmatism values of all data

Best-corrected Visual Acuity

BCVA improved for 19 eyes 3 years postoperatively (65.6%, n = 29), while for one, it did not change (10.3%), and seven eyes lost at least one line (24.1%). Of these 7 eyes 4 eyes lost 1 line, 1 eye lost 2 lines and 2 eyes lost 4 lines.

The mean BCVA at 1 year (n = 40) and 3 years (n = 22) was 0.14 logMAR (SD 0.17; median 0.10 logMAR; range −0.08 to 0.70 logMAR) and 0.21 logMAR (SD 0.21; median 0.15 logMAR; range 0.0–1.0 logMAR), respectively. The difference between 1 and 3 years was statistically significant (p = 0.010; n = 20).

The mean change in BCVA 3 years after the operation was 0.07 logMAR (SD 0.11, median 0.06 logMAR, range −0.12 – 0.30 logMAR).

CONCLUSION

Presently, most measures aim to improve vision by strengthening the thinned-out cornea with different types of intracorneal rings. There is no information on parenchymal healing with a ring itself. Healing in the sense of scarring without loss of transparency still seems out of scope of therapeutic applicability.

Circular keratotomy performed either mechanically or with a femtosecond laser, as presented in this paper, has the principal advantage of limiting the generation of scar tissue to the planned 7-mm zone. Limiting the cut from above Descemet’s to below Bowman’s seems to bring the advantage of a highly transparent scar. Extending the procedure to stage III keratoconic corneas most likely will result in a non-transparent 7-mm circle.

If the femtosecond laser is used, there is no opening of the cornea thereby possibly contacting the outside world. The paper confirms stable radii over 3 years in 87.8% without any notable side effects.

REFERENCES

1. Colin J, Cochener B, Savary G, et al. Correcting keratoconus with intracorneal rings. J Cataract Refract Surg 2000; 26(8):1117–1122.

2. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-ainduced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003; 135(5):620–627.

3. Krumeich, JH, Brand Saberi B, Chankiewitz V, et al. and Guthoff R. (2014). Induction of neoplasia after deep anterior lamellar keratoplasty in a CXL-treated cornea. Cornea, 33(3): 313–316.

4. Krumeich JH, Kezirian GM. Circular keratotomy to reduce astigmatism and improve vision in stage I and II keratoconus. J Refract Surg 2009;25(4):357–365.

5. Krumeich JH, Hirnschall N. Effect of Circular Keratotomy on Progression of Keratoconus. Int J Kerat Ect Cor Dis 2016; 5(2):57–62.

6. Alio JL, Piñero DP, Daxer A. Clinical outcomes after complete ring implantation in corneal ectasia using the femtosecond technology: a pilot study. Ophthalmology 2011;118(7): 1282–1290.

7. Krumeich JH, Hirnschall N, Breyer D, Laufer F. Femto Circular Keratotomy to Halt the Progression of Keratoconus I and II. Int J Kerat Ect Cor Dis 016;5(3):109–113.

8. Wilson SL, El Haj AJ, Yang Y. Control of scar tissue formation in the cornea: strategies in clinical and corneal tissue engineering. Journal of functional biomaterials, 3(3): 642–687.

________________________
© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.